Astera Labs (NASDAQ: ALAB) has recently received a number of price target changes and ratings updates:
- 1/21/2026 – Astera Labs had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
- 1/15/2026 – Astera Labs was given a new $165.00 price target on by analysts at Barclays PLC.
- 1/14/2026 – Astera Labs is now covered by analysts at Royal Bank Of Canada. They set an “outperform” rating and a $225.00 price target on the stock.
- 1/14/2026 – Astera Labs is now covered by analysts at Royal Bank Of Canada. They set an “outperform” rating and a $225.00 price target on the stock.
- 12/9/2025 – Astera Labs had its price target raised by analysts at Northland Securities from $175.00 to $195.00. They now have an “outperform” rating on the stock.
- 12/9/2025 – Astera Labs had its “outperform” rating reaffirmed by analysts at Citigroup Inc..
- 12/3/2025 – Astera Labs had its “overweight” rating reaffirmed by analysts at Morgan Stanley. They now have a $210.00 price target on the stock.
- 12/3/2025 – Astera Labs had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc..
Insider Activity
In related news, Director Manuel Alba sold 150,000 shares of Astera Labs stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the completion of the transaction, the director owned 1,574,498 shares in the company, valued at $261,650,077.64. The trade was a 8.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jitendra Mohan sold 90,459 shares of the company’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the transaction, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at $301,015,680.42. The trade was a 4.17% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 576,936 shares of company stock worth $87,409,540. 12.50% of the stock is currently owned by corporate insiders.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Recommended Stories
- Five stocks we like better than Astera Labs
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Astera Labs Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs Inc and related companies with MarketBeat.com's FREE daily email newsletter.
